News
02-10-2021, 10:48 PM
Oncotarget recently published "Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment" which reported that a retrospective study included 955 patients of various stages of prostate cancer who received combined hormone radiation treatment from 2000 to 2019.
More... (https://www.news-medical.net/news/20210211/Researchers-analyze-overall-survival-rate-of-prostate-cancer-patients-treated-with-melatonin.aspx)
More... (https://www.news-medical.net/news/20210211/Researchers-analyze-overall-survival-rate-of-prostate-cancer-patients-treated-with-melatonin.aspx)